Wpływ dysbiozy mikrobioty jelitowej na choroby układu sercowo-naczyniowego

Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, i in. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12–85. doi:10.1093/eurheartj/ehz859

Nasr SH, Radhakrishnan J, D’Agati VD. Bacterial infection-related glomerulonephritis in adults. Kidney Int. 2013;83(5):792–803. doi:10.1038/ki.2012.407

Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010;50(12):1641–52. doi:10.1086/652861

Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208(2):233–48. doi:10.1002/path.1868

Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, i in. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6(26):22613–23. doi:10.18632/oncotarget.4209

Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 2013;34(10):2193–7. doi:10.1093/carcin/bgt249

Farsimadan M, Motamedifar M. Bacterial infection of the male reproductive system causing infertility. J Reprod Immunol. 2020;142:103183. doi:10.1016/j.jri.2020.103183

Winter G, Hart RA, Charlesworth RPG, Sharpley CF. Gut microbiome and depression: what we know and what we need to know. Rev Neurosci. 2018;29(6):629–43. doi:10.1515/revneuro-2017-0072

Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, i in. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30(3):350–8. doi:10.1002/mds.26069

Jiménez E, Fernández L, Marín ML, Martín R, Odriozola JM, Nueno-Palop C, i in. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51(4):270–4. doi:10.1007/s00284-005-0020-3

Lauder AP, Roche AM, Sherrill-Mix S, Bailey A, Laughlin AL, Bittinger K, i in. Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota. Microbiome. 2016;4:29. doi:10.1186/s40168-016-0172-3

Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, i in. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–5. doi:10.1073/pnas.1002601107

Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev. 2010;86 Suppl 1:13–5. doi:10.1016/j.earlhumdev.2010.01.004

Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012;3(3):203–20. doi:10.4161/gmic.20169

Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, i in. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev. 2017;81(4):e00036-17. doi:10.1128/MMBR.00036-17

Aujoulat F, Roudière L, Picaud J-C, Jacquot A, Filleron A, Neveu D, i in. Temporal dynamics of the very premature infant gut dominant microbiota. BMC Microbiol. 2014;14:325. doi:10.1186/s12866-014-0325-0

Collado MC, Isolauri E, Laitinen K, Salminen S. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92(5):1023–30. doi:10.3945/ajcn.2010.29877

Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, i in. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–21. doi:10.1542/peds.2005-2824

Lin A, Bik EM, Costello EK, Dethlefsen L, Haque R, Relman DA, i in. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One. 2013;8(1):e53838. doi:10.1371/journal.pone.0053838

Stewart JA, Chadwick VS, Murray A. Investigations into the influence of host genetics on the predominant eubacteria in the faecal microflora of children. J Med Microbiol. 2005;54(Pt 12):1239–42. doi:10.1099/jmm.0.46189-0

Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe. 2011;17(6):478–82. doi:10.1016/j.anaerobe.2011.03.009

Davis MY, Zhang H, Brannan LE, Carman RJ, Boone JH. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome. 2016;4(1):53. doi:10.1186/s40168-016-0198-6

Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, i in. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7. doi:10.1038/nature11053

Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, i in. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. doi:10.1016/j.ebiom.2019.11.051

Cukrowska B, Bierła JB, Zakrzewska M, Klukowski M, Maciorkowska E. The Relationship between the Infant Gut Microbiota and Allergy. The Role of Bifidobacterium breve and Prebiotic Oligosaccharides in the Activation of Anti-Allergic Mechanisms in Early Life. Nutrients. 2020;12(4):946. doi:10.3390/nu12040946

Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573–84. doi:10.1038/nrgastro.2017.88

Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473–93. doi:10.1007/s00018-018-2943-4

Takiishi T, Fenero CIM, Câmara NOS. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208. doi:10.1080/21688370.2017.1373208

Sommer F, Bäckhed F. The gut microbiota--masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–38. doi:10.1038/nrmicro2974

Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, i in. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res. 2021;172:105840. doi:10.1016/j.phrs.2021.105840

Maria Trusz-Gluza, Wiktoria Leśniak. Migotanie przedsionków (AF). Dostępne na: https://www.mp.pl/interna/chapter/B16.II.2.6.6.

Spencer TM, Blumenstein RF, Pryse KM, Lee S-L, Glaubke DA, Carlson BE, i in. Fibroblasts Slow Conduction Velocity in a Reconstituted Tissue Model of Fibrotic Cardiomyopathy. ACS Biomater Sci Eng. 2017;3(11):3022–8. doi:10.1021/acsbiomaterials.6b00576

Yoo S, Aistrup G, Shiferaw Y, Ng J, Mohler PJ, Hund TJ, i in. Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure. JCI Insight. 2018;3(21):e120728, 120728. doi:10.1172/jci.insight.120728

Xie W, Santulli G, Reiken SR, Yuan Q, Osborne BW, Chen B-X, i in. Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep. 2015;5:11427. doi:10.1038/srep11427

Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR, i in. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010;31(14):1730–6. doi:10.1093/eurheartj/ehq146

Zhang Y, Zhang S, Li B, Luo Y, Gong Y, Jin X, i in. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res. 2022;118(3):785–97. doi:10.1093/cvr/cvab114

Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, i in. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience. 2019;8(6):giz058. doi:10.1093/gigascience/giz058

Kong B, Fu H, Xiao Z, Zhou Y, Shuai W, Huang H. Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation. Can J Cardiol. 2022;38(12):1962–75. doi:10.1016/j.cjca.2022.08.231

Yao C, Veleva T, Scott L, Cao S, Li L, Chen G, i in. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation. 2018;138(20):2227–42. doi:10.1161/CIRCULATIONAHA.118.035202

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, i in. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:10.1186/s40168-016-0222-x

Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, i in. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–40. doi:10.1161/HYPERTENSIONAHA.115.05315

Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, i in. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension. Redox Biol. 2021;46:102115. doi:10.1016/j.redox.2021.102115

Yang F, Chen H, Gao Y, An N, Li X, Pan X, i in. Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment. Biomed Pharmacother. 2020;130:110503. doi:10.1016/j.biopha.2020.110503

Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS. 2020;128(5):353–66. doi:10.1111/apm.13038

Chou R-H, Chen C-Y, Chen I-C, Huang H-L, Lu Y-W, Kuo C-S, i in. Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina. Sci Rep. 2019;9(1):4249. doi:10.1038/s41598-019-40638-y

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, i in. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–64. doi:10.1016/j.jacc.2018.08.1038

Qian X, Liu A, Liang C, He L, Xu Z, Tang S. Analysis of gut microbiota in patients with acute myocardial infarction by 16S rRNA sequencing. Ann Transl Med. 2022;10(24):1340. doi:10.21037/atm-22-5671

Han Y, Gong Z, Sun G, Xu J, Qi C, Sun W, i in. Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction. Front Microbiol. 2021;12:680101. doi:10.3389/fmicb.2021.680101

Anna Członkowska, Maciej Niewada. Udar mózgu. Dostępne na: https://www.mp.pl/interna/chapter/B16.II.2.29.

Benakis C, Poon C, Lane D, Brea D, Sita G, Moore J, i in. Distinct commensal bacterial signature in the gut is associated with acute and long-term protection from ischemic stroke. Stroke. 2020;51(6):1844–54. doi:10.1161/STROKEAHA.120.029262

Chen Y, Liang J, Ouyang F, Chen X, Lu T, Jiang Z, i in. Persistence of Gut Microbiota Dysbiosis and Chronic Systemic Inflammation After Cerebral Infarction in Cynomolgus Monkeys. Front Neurol. 2019;10:661. doi:10.3389/fneur.2019.00661

Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, i in. Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. J Neurosci. 2016;36(28):7428–40. doi:10.1523/JNEUROSCI.1114-16.2016

Yin J, Liao S-X, He Y, Wang S, Xia G-H, Liu F-T, i in. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. J Am Heart Assoc. 2015;4(11):e002699. doi:10.1161/JAHA.115.002699

Kim S-K, Guevarra RB, Kim Y-T, Kwon J, Kim H, Cho JH, i in. Role of Probiotics in Human Gut Microbiome-Associated Diseases. J Microbiol Biotechnol. 2019;29(9):1335–40. doi:10.4014/jmb.1906.06064

Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy J-M, Dequenne I, i in. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2019;9:454. doi:10.3389/fcimb.2019.00454

Holvoet T, Joossens M, Wang J, Boelens J, Verhasselt B, Laukens D, i in. Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating. Gut. 2017;66(5):980–2. doi:10.1136/gutjnl-2016-312513

Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, i in. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17–24. doi:10.1016/S2468-1253(17)30338-2

Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019–40. doi:10.1007/s10482-020-01474-7

Liu B-N, Liu X-T, Liang Z-H, Wang J-H. Gut microbiota in obesity. World J Gastroenterol. 2021;27(25):3837–50. doi:10.3748/wjg.v27.i25.3837